The trial was a double-blind, randomised, placebo-controlled trial of pravastatin in patients with a history of unstable angina or myocardial infarction.
The patients had initial cholesterol levels of 4.0 - 7.0 mmol/litre.
9014 patients were recruited between the ages of 31 and 75.
The mean follow-up period was 6.1 years.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page